Creatine inhibits adipogenesis by downregulating insulin-induced activation of the phosphatidylinositol 3-kinase signaling pathway

Stem Cells and Development

Volumn 24, Issue 8, 2015, Pages 983-994

  Lee, Nayeon ^a   Kim, Inhee ^a   Park, Soojeong ^a   Han, Dasol ^a   Ha, Soobong ^a   Kwon, Mookwang ^a   Kim, Juwan ^a   Byun, Sung Hyun ^a   Oh, Wonil ^b   Jeon, Hong Bae ^b   Kweon, Dae Hyuk ^a   Cho, Jae Youl ^a   Yoon, Keejung ^a  

^a Sungkyunkwan University   (South Korea)

^b MEDIPOST Co Ltd   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; COMPLEMENT FACTOR D; CREATINE; FATTY ACID BINDING PROTEIN 4; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 4; INSULIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TRIACYLGLYCEROL; FATTY ACID BINDING PROTEIN;

3T3 CELL LINE; ABDOMINAL FAT; ADIPOCYTE; ADIPOGENESIS; ANIMAL EXPERIMENT; ARTICLE; CELL DIFFERENTIATION; CELL ENERGY; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; ENERGY METABOLISM; ENZYME ACTIVATION; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; LIPID STORAGE; MALE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROADIPOCYTE; PROGENITOR CELL LINE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM;

MUS;

3T3 CELLS; ADIPOGENESIS; ANIMALS; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CELLS, CULTURED; COMPLEMENT FACTOR D; CREATINE; DOWN-REGULATION; FATTY ACID-BINDING PROTEINS; GLUCOSE TRANSPORTER TYPE 1; GLUCOSE TRANSPORTER TYPE 4; HUMANS; INSULIN; MALE; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C57BL; PHOSPHATIDYLINOSITOL 3-KINASES; PPAR GAMMA; SIGNAL TRANSDUCTION; TRIGLYCERIDES;

EID: 84926466021     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2014.0130     Document Type: Article

References (52)

1. Hsu IR, SP Kim, M Kabir and RN Bergman. (2007). Metabolic syndrome, hyperinsulinemia, and cancer. Am J Clin Nutr 86:867S-871S.
2. Kong Z-L. (2007). Conjugated linoleic acid and weight control; from the biomedical immune viewpoint. In: Obesity: Epidemiology, Pathophysiology, and Prevention. Bagchi D, Preuss H, eds. CRC Press, Boca Raton, FL, pp. 383-399.
3. Moreno-Navarrete JM and JM Fernández-Real. (2012). Adipocyte differentiation. In: Adipose Tissue Biology. Symonds ME, ed. Springer, New York, pp 17-38.
4. Hirsch J and B Batchelor. (1976). Adipose tissue cellularity in human obesity. Clin Endocrinol Metab 5:299-311.
5. Pittenger MF, AM Mackay, SC Beck, RK Jaiswal, R Douglas, JD Mosca, MA Moorman, DW Simonetti, S Craig and DR Marshak. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
6. Lin FT and MD Lane. (1994). CCAAT/enhancer binding protein alpha is sufficient to initiate the 3T3-L1 adipocyte differentiation program. Proc Natl Acad Sci U S A 91:8757-8761.
7. Tontonoz P, E Hu and BM Spiegelman. (1994). Stimulation of adipogenesis in fibroblasts by PPARgamma2, a lipidactivated transcription factor. Cell 79:1147-1156.
8. Tang QQ and MD Lane. (2012). Adipogenesis: from stem cell to adipocyte. Annu Rev Biochem 81:715-736.
9. Rosen ED, C-H Hsu, X Wang, S Sakai, MW Freeman, FJ Gonzalez and BM Spiegelman. (2002). C/EBPa induces adipogenesis through PPAR gamma: a unified pathway. Genes Dev 16:22-26.
10. Takada I, AP Kouzmenko and S Kato. (2009). Wnt and PPAR[gamma] signaling in osteoblastogenesis and adipogenesis. Nat Rev Rheumatol 5:442-447.
11. Bonfanti L. (2013). The (real) neurogenic/gliogenic potential of the postnatal and adult brain parenchyma. ISRN Neurosci 2013:14.
12. Kawai M and CJ Rosen. (2010). PPAR[gamma]: a circadian transcription factor in adipogenesis and osteogenesis. Nat Rev Endocrinol 6:629-636.
13. Brosnan JT and ME Brosnan. (2007). Creatine: endogenous metabolite, dietary, and therapeutic supplement. Annu Rev Nutr 27:241-261.
14. Wyss M and R Kaddurah-Daouk. (2000). Creatine and creatinine metabolism. Physiol Rev 80:1107-1213.
15. Mujika I and S Padilla. (1997). Creatine supplementation as an ergogenic aid for sports performance in highly trained athletes: a critical review. Int J Sports Med 18:491-496.
16. Salomons G and M Wyss. (2007). Creatine and creatine kinase in health and disease. Subcellular Biochemistry. Springer, Dordrecht.
17. Wallimann T, M Tokarska-Schlattner and U Schlattner. (2011). The creatine kinase system and pleiotropic effects of creatine. Amino Acids 40:1271-1296.
18. Louis M, R Van Beneden, M Dehoux, JP Thissen and M Francaux. (2004). Creatine increases IGF-I and myogenic regulatory factor mRNA in C2C12 cells. FEBS Lett 557:243-247.
19. Deldicque L, D Theisen, L Bertrand, P Hespel, L Hue and M Francaux. (2007). Creatine enhances differentiation of myogenic C2C12 cells by activating both p38 and Akt/ PKB pathways. Am J Physiol Cell Physiol 293:C1263-C1271.
20. Deldicque L, P Atherton, R Patel, D Theisen, H Nielens, MJ Rennie and M Francaux. (2008). Effects of resistance exercise with and without creatine supplementation on gene expression and cell signaling in human skeletal muscle. J Appl Physiol 104:371-378.
21. Gerber I, Ia Gwynn, M Alini and T Wallimann. (2005). Stimulatory effects of creatine on metabolic activity, differentiation and mineralization of primary osteoblast-like cells in monolayer and micromass cell cultures. Eur Cell Mater 10:8-22.
22. Yang SE, CW Ha, MH Jung, HJ Jin, MK Lee, HS Song, SJ Choi, W Oh and YS Yang. (2004). Mesenchymal stem/ progenitor cells developed in cultures from UC blood. Cytotherapy 6:476-486.
23. Green H and M Meuth. (1974). An established pre-adipose cell line and its differentiation in culture. Cell 3:127-133.
24. Russell TR and R Ho. (1976). Conversion of 3T3 fibroblasts into adipose cells: triggering of differentiation by prostaglandin F2alpha and 1-methyl-3-isobutyl xanthine. Proc Natl Acad Sci U S A 73:4516-4520.
25. Rubin CS, A Hirsch, C Fung and OM Rosen. (1978). Development of hormone receptors and hormonal responsiveness in vitro. Insulin receptors and insulin sensitivity in the preadipocyte and adipocyte forms of 3T3-L1 cells. J Biol Chem 253:7570-7578.
26. Caprio M, B Feve, A Claes, S Viengchareun, M Lombes and M-C Zennaro. (2007). Pivotal role of the mineralocorticoid receptor in corticosteroid-induced adipogenesis. FASEB J 21:2185-2194.
27. Berger J and DE Moller. (2002). The mechanisms of action of PPARs. Annu Rev Med 53:409-435.
28. Styner M, B Sen, Z Xie, N Case and J Rubin. (2010). Indomethacin promotes adipogenesis of mesenchymal stem cells through a cyclooxygenase independent mechanism. J Cell Biochem 111:1042-1050.
29. Wu Z, Y Xie, RF Morrison, NL Bucher and SR Farmer. (1998). PPARgamma induces the insulin-dependent glucose transporter GLUT4 in the absence of C/EBPalpha during the conversion of 3T3 fibroblasts into adipocytes. J Clin Invest 101:22-32.
30. Noh KH, TH Kang, JH Kim, SI Pai, KY Lin, C-F Hung, T-C Wu and TW Kim. (2009). Activation of Akt as a mechanism for tumor immune evasion. Mol Ther 17:439-447.
31. Jang J, J Lee, S-T Kim, K-Y Lee, JY Cho, D-H Kweon, S-T Kwon, YH Koh, S Kim and K Yoon. (2012). Polycationmediated enhancement of retroviral transduction efficiency depends on target cell types and pseudotyped Env proteins: implication for gene transfer into neural stem cells. Neurochem Int 60:846-851.
32. Hauser S, G Adelmant, P Sarraf, HM Wright, E Mueller and BM Spiegelman. (2000). Degradation of the peroxisome proliferator-activated receptor gamma is linked to ligand-dependent activation. J Biol Chem 275:18527-18533.
33. Yang M-S, J-S Hong, S-T Kim, K-Y Lee, KW Park, S-T Kwon, D-H Kweon, YH Koh, N Gaiano and K Yoon. (2011). Among gamma-secretase substrates Notch1 alone is sufficient to block neurogenesis but does not confer selfrenewal properties to neural stem cells. Biochem Biophys Res Commun 404:133-138.
34. Green H and O Kehinde. (1976). Spontaneous heritable changes leading to increased adipose conversion in 3T3 cells. Cell 7:105-113.
35. Reznikoff CA, DW Brankow and C Heidelberger. (1973). Establishment and characterization of a cloned line of C3H mouse embryo cells sensitive to postconfluence inhibition of division. Cancer Res 33:3231-3238.
36. Pinney DF and CPJ Emerson. (1989). 10T1/2 cells: an in vitro model for molecular genetic analysis of mesodermal determination and differentiation. Environ Health Perspect 80:221-227.
37. Rangwala SM and MA Lazar. (2000). Transcriptional control of adipogenesis. Annu Rev Nutr 20:535-559.
38. Cook KS, DL Groves, HY Min and BM Spiegelman. (1985). A developmentally regulated mRNA from 3T3 adipocytes encodes a novel serine protease homologue. Proc Natl Acad Sci U S A 82:6480-6484.
39. Olson AL and JE Pessin. (1996). Structure, function, and regulation of the mammalian facilitative glucose transporter gene family. Annu Rev Nutr 16:235-256.
40. Liao W, MTA Nguyen, T Imamura, O Singer, IM Verma and JM Olefsky. (2006). Lentiviral short hairpin ribonucleic acid-mediated knockdown of GLUT4 in 3T3-L1 adipocytes. Endocrinology 147:2245-2252.
41. Garofalo RS, SJ Orena, K Rafidi, AJ Torchia, JL Stock, AL Hildebrandt, T Coskran, SC Black, DJ Brees, et al. (2003). Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKB beta. J Clin Invest 112:197-208.
42. Kim JE and J Chen. (2004). Regulation of peroxisome proliferator-activated receptor-gamma activity by mammalian target of rapamycin and amino acids in adipogenesis. Diabetes 53:2748-2756.
43. Aouadi M, K Laurent, M Prot, Y Le Marchand-Brustel, B Binétruy and F Bost. (2006). Inhibition of p38MAPK increases adipogenesis from embryonic to adult stages. Diabetes 55:281-289.
44. Volek JS, ND Duncan, SA Mazzetti, RS Staron, M Putukian, AL Gómez, DR Pearson, WJ Fink and WJ Kraemer. (1999). Performance and muscle fiber adaptations to creatine supplementation and heavy resistance training. Med Sci Sports Exerc 31:1147-1156.
45. Persky AM and GA Brazeau. (2001). Clinical pharmacology of the dietary supplement creatine monohydrate. Pharmacol Rev 53:161-176.
46. Ingwall JS, MF Morales and FE Stockdale. (1972). Creatine and the control of myosin synthesis in differentiating skeletal muscle. Proc Natl Acad Sci U S A 69:2250-2253.
47. Ingwall JS, CD Weiner, MF Morales, E Davis and FE Stockdale. (1974). Specificity of creatine in the control of muscle protein synthesis. J Cell Biol 62:145-151.
48. Parise G, S Mihic, D MacLennan, KE Yarasheski and MA Tarnopolsky. (2001). Effects of acute creatine monohydrate supplementation on leucine kinetics and mixed-muscle protein synthesis. J Appl Physiol 91:1041-1047.
49. Dangott B, E Schultz and PE Mozdziak. (2000). Dietary creatine monohydrate supplementation increases satellite cell mitotic activity during compensatory hypertrophy. Int J Sports Med 21:13-16.
50. Spinella-Jaegle S, G Rawadi, S Kawai, S Gallea, C Faucheu, P Mollat, B Courtois, B Bergaud, V Ramez, et al. (2001). Sonic hedgehog increases the commitment of pluripotent mesenchymal cells into the osteoblastic lineage and abolishes adipocytic differentiation. J Cell Sci 114: 2085-2094.
51. Kohn AD, SA Summers, MJ Birnbaum and RA Roth. (1996). Expression of a constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation. J Biol Chem 271: 31372-31378.
52. Tontonoz P, E Hu, J Devine, EG Beale and BM Spiegelman. (1995). PPAR gamma 2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene. Mol Cell Biol 15:351-357.